MACKENZIE FINANCIAL CORP

Position in AGEN — Agenus Inc

CIK 919859 TORONTO ONTARIO, A6

Position in AGEN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,185,375

+$2,170,703 QoQ

Shares Held

714,175

+80689.0% QoQ

Ownership

1.59%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 103 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. AGEN ranks #37 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	135,783	$84,666,131
2	INCY	Incyte Corp	634,862	$71,967,956
3	BMRN	Biomarin Pharmaceutical Inc	931,864	$53,321,258
4	VRTX	Vertex Pharmaceuticals Inc / Ma	102,928	$51,127,425
5	BBIO	BridgeBio Pharma, Inc.	298,440	$22,227,811
6	TBPH	Theravance Biopharma, Inc.	985,848	$16,759,416
7	RPRX	Royalty Pharma plc	270,457	$15,164,523
8	ALNY	Alnylam Pharmaceuticals, Inc.	43,988	$13,241,707

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,185,375	714,175	+3939.9%	Shares	Sole	2026-08-13
2023-12-31	$14,672	17,678	0.0%	Shares	Sole	2024-01-30
2023-09-30	$19,976	17,678	-54.2%	Shares	Sole	2023-10-25
2023-06-30	$61,808	38,630	+68.8%	Shares	Sole	2023-08-03
2023-03-31	$34,780	22,882	+29.4%	Shares	Sole	2023-04-24
2022-12-31	$42,427	17,678	-41.6%	Shares	Sole	2023-02-14
2022-09-30	$62,067	30,277	-5.5%	Shares	Sole	2022-10-07
2022-06-30	$62,163	32,043	-8.3%	Shares	Sole	2022-08-10
2022-03-31	$85,999	34,959	+11.0%	Shares	Sole	2022-05-13
2021-12-31	$101,423	31,498	+28.2%	Shares	Sole	2022-02-14
2021-09-30	$128,997	24,571	+141.2%	Shares	Sole	2021-11-08
2021-06-30	$55,915	10,185	—	Shares	Sole	2021-08-11
No filing history on record for this holder in this stock.